Impact of smoking on the effectiveness of different non-small-cell lung cancer therapies

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Prognostic stratification through smoking status and cumulative smoking dose in advanced non-small cell lung cancer immunotherapy: a dose-dependent real-world analysis2025
2. 2Real‐World Evidence That Non‐Smokers With High <scp>PD</scp>‐<scp>L1</scp> Non‐Squamous <scp>NSCLC</scp> Have Poorer Outcomes With Immune Checkpoint Inhibitors2025
3. 3Role of Smoking Status on Long-Term Survival in Patients Operated for Non-Small Cell Lung Cancer2025
4. 4Comparing nivolumab response between smokers and ex-smokers in advanced non-small cell lung cancer: It is never too late to quit smoking2025
5. 5Lung Cancer in Non-Smokers: Integrating Histopathological Patterns, Molecular Profiles and Therapeutic Strategies2025